Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review protocol
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4598088
Author(s) Appenzeller-Herzog, Christian; Hartleif, Steffen; Vionnet, Julien
Author(s) at UniBasel Appenzeller-Herzog, Christian
Year 2019
Title Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review protocol
Journal F1000Research
Volume 8
Pages / Article-Number 2059
Keywords Tregs; biomarker; clinical parameter; flow cytometry; gene expression profiling; immunosuppression; immunosuppression withdrawal; liver biopsy; liver transplantation; operational tolerance; regulatory lymphocytes; scoping review
Abstract Objective:; This scoping review aims at systematically mapping reported prognostic factors for spontaneous immunosuppression (IS) free allograft tolerance (operational tolerance, OT) in non-viral hepatitis and non-autoimmune disease liver transplant (LT) recipients who are undergoing immunosuppression withdrawal (ISW). The results may inform the subsequent conduct of a systematic review with a more specific review question.; Background:; LT is currently the most effective treatment for end-stage liver diseases. Whereas the short-term outcomes after LT have dramatically improved over the last decades, the long-term outcomes remain unsatisfactory, mainly because of side effects of lifelong IS, such as infections, cardiovascular diseases, malignancies, and nephrotoxicity. ISW studies have shown that OT can be achieved by a subset of LT recipients and recent research has identified biomarkers of OT in these patients. However, an evidence-based selection algorithm for patients that can predictably benefit from ISW is not available to date. The planned review will, therefore, map existing knowledge on prognostic clinical parameters and biomarkers for OT.; Inclusion criteria:; We will consider studies that record any clinical parameter or biomarker before the initiation of ISW in paediatric or adult non-viral hepatitis and non-autoimmune disease LT recipients and analyse their possible association with ISW outcomes (OT or non-tolerance). Studies addressing the effectiveness of OT-inducing treatments will be excluded.; Methods:; Embase, MEDLINE, and Cochrane Library will be searched for relevant articles or conference abstracts. Full-texts of selected abstracts will be independently screened for inclusion by two reviewers. References and citing articles of included records will be screened for additional relevant records. Clinical trial registries will be searched for ongoing studies, and their investigators contacted for the sharing of unpublished data. Data from included records will be independently extracted by two reviewers using a prespecified data extraction table and presented in both tabular and narrative form.
Publisher F1000 Research
ISSN/ISBN 2046-1402
URL https://f1000research.com/articles/8-2059/v2
edoc-URL https://edoc.unibas.ch/76698/
Full Text on edoc Available
Digital Object Identifier DOI 10.12688/f1000research.21501.2
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/32399186
ISI-Number MEDLINE:32399186
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.321 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
14/05/2024